GB0201819D0 - Human posh-like protein 1 - Google Patents

Human posh-like protein 1

Info

Publication number
GB0201819D0
GB0201819D0 GBGB0201819.0A GB0201819A GB0201819D0 GB 0201819 D0 GB0201819 D0 GB 0201819D0 GB 0201819 A GB0201819 A GB 0201819A GB 0201819 D0 GB0201819 D0 GB 0201819D0
Authority
GB
United Kingdom
Prior art keywords
protein
human posh
posh
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0201819.0A
Other versions
GB2379662A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeomica Inc
Original Assignee
Aeomica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2001/000667 external-priority patent/WO2001057275A2/en
Priority claimed from US09/864,761 external-priority patent/US20020048763A1/en
Application filed by Aeomica Inc filed Critical Aeomica Inc
Publication of GB0201819D0 publication Critical patent/GB0201819D0/en
Publication of GB2379662A publication Critical patent/GB2379662A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • A61P33/12Schistosomicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GB0201819A 2001-01-30 2002-01-28 Human POSH-like protein 1 Withdrawn GB2379662A (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
PCT/US2001/000667 WO2001057275A2 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
PCT/US2001/000666 WO2001057274A2 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
PCT/US2001/000665 WO2001086003A2 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung
PCT/US2001/000663 WO2001057272A2 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta
PCT/US2001/000664 WO2001057273A2 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver
PCT/US2001/000669 WO2001057277A2 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver
PCT/US2001/000670 WO2001057278A2 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells
PCT/US2001/000668 WO2001057276A2 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
US09/864,761 US20020048763A1 (en) 2000-02-04 2001-05-23 Human genome-derived single exon nucleic acid probes useful for gene expression analysis
US32820501P 2001-10-10 2001-10-10

Publications (2)

Publication Number Publication Date
GB0201819D0 true GB0201819D0 (en) 2002-03-13
GB2379662A GB2379662A (en) 2003-03-19

Family

ID=46150066

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0201819A Withdrawn GB2379662A (en) 2001-01-30 2002-01-28 Human POSH-like protein 1

Country Status (1)

Country Link
GB (1) GB2379662A (en)

Also Published As

Publication number Publication date
GB2379662A (en) 2003-03-19

Similar Documents

Publication Publication Date Title
GB0130228D0 (en) Protein
EP1391209A4 (en) Protein formulations
IL161291A0 (en) Human 3 relaxin
EP1365022A4 (en) Adiponectin-associated protein
GB0218205D0 (en) Human ZZAP1 protein
GB0108079D0 (en) Protein
EP1368468A4 (en) 83 human secreted proteins
AU2003301843A8 (en) 157 human secreted proteins
EP1370651A4 (en) 70 human secreted proteins
GB0410147D0 (en) Human angiomotin-like protein 1
AU2002365153A1 (en) 41 human secreted proteins
EP1404807A4 (en) 20 human secreted proteins
GB0201681D0 (en) Human ralgds-like protein 3
GB0201819D0 (en) Human posh-like protein 1
AU2002246998A1 (en) 50 human secreted proteins
AU2002348034A8 (en) 16 human secreted proteins
GB0201011D0 (en) Human gtp-rho binding protein 2
AU2002257630A1 (en) Human mrp5-like protein
GB0130721D0 (en) Protein
GB0106318D0 (en) Protein
GB0201673D0 (en) Human UDP-Galnac:Polypeptide N-acetylgalactosaminyltransfera 10
AU2003211136A8 (en) 6 human secreted proteins
GB0119028D0 (en) Protein
GB0129661D0 (en) Protein
GB0119447D0 (en) Protein

Legal Events

Date Code Title Description
710B Request of alter time limits

Free format text: EXTENSION APPLICATION: APPLICATION FOR EXTENSION OF THE PERIOD(S) PRESCRIBED BY RULE(S) 6(2) FILED ON 20020621.

9110 Period prescribed has been extended under rule 110(6)/1990

Free format text: EXTENSION ALLOWED: PERIOD(S) PRESCRIBED BY RULE(S) 6(2) EXTENDED UNDER RULE 110(6) IN ACCORDANCE WITH THE DECISION OF THE COMPTROLLER DATED 20021219.

WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)